Zobrazeno 1 - 5
of 5
pro vyhledávání: '"P. S. Oturai"'
Autor:
P. L. Jørgensen, M. Kreiberg, N. Jørgensen, A. Juul, P. S. Oturai, C. Dehlendorff, J. Lauritsen, T. Wagner, J. Rosenvilde, G. Daugaard, C. R. Medici, N. R. Jørgensen, M. Bandak
Publikováno v:
Acta Oncologica. :1-7
Autor:
S. E. Bønløkke, M. S. Rand, B. Haddock, S. Arup, C. D. Smith, J. E. B. Jensen, P. Schwarz, P. Hovind, P. S. Oturai, L. T. Jensen, S. Møller, P. Eiken, K. H. Rubin, M. F. Hitz, B. Abrahamsen, N. R. Jørgensen
Publikováno v:
Osteoporosis International. 33:2155-2164
Autor:
S E, Bønløkke, M S, Rand, B, Haddock, S, Arup, C D, Smith, J E B, Jensen, P, Schwarz, P, Hovind, P S, Oturai, L T, Jensen, S, Møller, P, Eiken, K H, Rubin, M F, Hitz, B, Abrahamsen, N R, Jørgensen
Publikováno v:
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 33(10)
Anti-resorptive osteoporosis treatment might be more effective in patients with high bone turnover. In this registry study including clinical data, high pre-treatment bone turnover measured with biochemical markers was correlated with higher bone min
Publikováno v:
Acta Neurologica Scandinavica. 137:363-369
Background Multiple sclerosis (MS) patients are at increased risk of reduced bone mineral density (BMD) and fractures. The aetiology of bone loss in MS is unclear. Trabecular bone score (TBS) is a novel analytical tool that provides a measurement of
Publikováno v:
Multiple sclerosis (Houndmills, Basingstoke, England). 21(12)
Background: Patients with multiple sclerosis (MS) are at increased risk of reduced bone mineral density (BMD). A contributing factor might be treatment with high-dose glucocorticoids (GCs). Objectives: The objective of this paper is to assess bone ma